The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $5.75

Today's change-0.17 -2.87%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $5.75

Today's change-0.17 -2.87%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc down (U.S.)$0.17

Spectrum Pharmaceuticals Inc closed sharply lower Friday, dropping (U.S.)$0.17 or 2.87% to (U.S.)$5.75. Over the last five days, shares are unchanged, but have gained 29.80% over the last year to date. This security has underperformed the S&P 500 by 38.30% during the last year.

Key company metrics

  • Open(U.S.) $5.92
  • Previous close(U.S.) $5.92
  • High(U.S.) $5.99
  • Low(U.S.) $5.69
  • Bid / Ask(U.S.) $5.70 / (U.S.) $7.86
  • YTD % change+29.80%
  • Volume541,102
  • Average volume (10-day)594,763
  • Average volume (1-month)851,478
  • Average volume (3-month)784,848
  • 52-week range(U.S.) $3.21 to (U.S.) $8.00
  • Beta1.71
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.08
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue29353334
Total other revenue--------
Total revenue29353334
Gross profit19242426
Total cost of revenue1011108
Total operating expense50534956
Selling / general / administrative19181928
Research & development15161314
Depreciation / amortization7776
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-21-17-16-22
Interest income (expense), net non-operating-2------
Gain (loss) on sale of assets--------
Other--------
Income before tax-23-19-18-24
Income after tax-23-17-17-24
Income tax, total0-200
Net income-23-17-17-24
Total adjustments to net income--------
Net income before extra. items-23-17-17-24
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-23-17-17-24
Inc. avail. to common incl. extra. items-23-17-17-24
Diluted net income-23-17-17-24
Dilution adjustment0------
Diluted weighted average shares79807969
Diluted EPS excluding extraordinary itemsvalue per share-0.29-0.22-0.22-0.35
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.29-0.22-0.22-0.35